Medicaid

Pharmalot

Pharmalot

How a patient advocacy group is used to promote an Insys drug and other fentanyl meds

By Ed Silverman

Vertex

Pharmalot

New York panel to review Vertex pricing in first test of new law

By Ed Silverman

advertisement

Pill pack

Business

Feds broaden the definition of ‘pharmacy’ in a bid to level playing field for startups

advertisement

Generics

Pharmalot

To boost generic competition, analysis says, FDA should approve drugs OK’d by foreign regulators

By Ed Silverman

Patient data and tech

Business

The government wants to free your health data. Will that unleash innovation?

Generic medication

Pharmalot

Vermont transparency pricing law may show big price hikes, but disappoints lawmakers

By Ed Silverman

Vertex

Pharmalot

Vertex battles with the U.K. over the price of its cystic fibrosis drug

By Ed Silverman

advertisement

Gilead Sciences

Pharmalot

HHS is urged to investigate a Gilead hepatitis C patent for failing to disclose federal funding

By Ed Silverman

advertisement

Medicaid work requirement

First Opinion

Medicaid work requirements are bad for patients and physicians

By Jack Ende

Elijah Cummings 2017

Pharmalot

Lawmakers urge HHS to sidestep patents on hepatitis C drugs

By Ed Silverman

SHAPE SORTER Meds

Pharma

Did the government overpay for hundreds of drugs? It’s complicated

By Ike Swetlitz

Alternative Medicine Symposium

Politics

As the opioid crisis grows, states are opening Medicaid to alternative medicine

Wedowee Hospital - Alabama

Hospitals

In states that didn’t expand Medicaid, hospital closures have spiked

Pharmalot

Pharmalittle: Pharma accounted for a lot of fraud last year; what becomes of Apotex?

By Ed Silverman

Three to Watch - Political Issues for Hospitals

Hospitals

3 political issues for hospitals to watch in 2018

Hospital medicaid

First Opinion

Physicians who refuse to accept Medicaid patients breach their contract with society

By Sumit Agarwal

Rising drug cost

Pharmalot

Arizona becomes the latest state to seek to limit Medicaid drug coverage

By Ed Silverman

Hep C San Fran

Pharmalot

Colorado lifts Medicaid restrictions for treating hepatitis C

By Ed Silverman

Hep C

Health

With cures in hand, a major city tries to eliminate hepatitis C — and build a model for others

By Andrew Joseph

Medication

First Opinion

Medicaid ‘best price’ approach to drug costs needs an upgrade

By Joel White

Remote Area Medical Treats Patients In Underserved Communities In Florida

First Opinion

The problem with American health care is the care

By Shreya Kangovi

Toby Cosgrove

Hospitals

Q&A: Forget repeal, says Toby Cosgrove. Focus on cutting regulations and drug prices

Seema Verma

Politics

Trump health official Seema Verma has a plan to slash Medicaid rolls. Here’s how

Child in hospital

First Opinion

We are America’s future doctors. We support a Medicare-for-all health system

By Augie Lindmark, Vanessa Van Doren, Bryant Shuey, and Andy Hyatt

Hepatitis C

Pharmalot

Some state Medicaid programs continue to restrict access to hepatitis C drugs

By Ed Silverman

Puerto Rico health

Health

The storm has passed, but Puerto Rico’s health faces prolonged recovery

By Carmen Heredia Rodriguez and Rachel Bluth — Kaiser Health News

Pfizer

Pharmalot

Pfizer loses battle to keep Medicaid rebate data hidden from Texas lawmakers

By Ed Silverman

Healthcare bill

First Opinion

Medicare innovation can spur the next round of payment reform

By Mark McClellan and Mike Leavitt

Drug Prices

Pharmalot

To lower costs, Massachusetts seeks to limit Medicaid drug coverage

By Ed Silverman